Summary#

ACR-220, Hepatitis B Awareness Month, is an enacted California Assembly concurrent resolution; it does not amend an existing Act. It declared June 2026 Hepatitis B Awareness Month and encouraged public agencies and others to take related steps. Its stated goal is to support public education and encourage vaccination, screening, treatment, and care.

• The resolution encourages the California Department of Public Health and other stakeholders to promote vaccination, including timely infant vaccination and completion of vaccine series.
• It encourages stakeholders to identify and work to remove barriers to vaccination, screening, testing, and treatment, including cost, coverage, language, and geographic barriers.
• It encourages targeted outreach using state and county hepatitis B data, and multidisciplinary advisory or working groups to help develop and review strategies.
• It encourages collaboration with regional and national partners and alignment with broader efforts on viral hepatitis and liver health.
• These are encouragements, not legal duties. The resolution creates no new program, benefit, fine, or individual requirement.

What it means for you#

• Individuals: The resolution does not require anyone to get vaccinated, tested, or treated. It does not change insurance coverage or payment rules.
• Health agencies, providers, health plans, community organizations, and other stakeholders: The Legislature encourages them to promote hepatitis B prevention and care and address barriers, but the resolution does not require specific actions.
• Californians generally: June 2026 was designated as Hepatitis B Awareness Month. That month has passed.

Money#

No cost estimate is provided in the available material.

• The resolution does not specify an appropriation, fee, or required staffing level.
• Outreach or other encouraged activities may have costs, but the material does not say whether they would use existing resources or require new spending.

What is unclear#

• What activities count as “appropriate” education and outreach, and who would decide.
• Whether agencies or other stakeholders will take up the recommendations, and how progress would be measured.
• Whether any advisory or working groups will be formed, who would take part, or what authority they would have.
• How much any expanded outreach or barrier-removal work would cost.

Case for#

• The resolution’s stated rationale is that many people with hepatitis B may not know they have it, while early detection and treatment can help prevent serious liver disease.
• Using local data to focus outreach could help direct attention to communities with higher numbers or rates of infection.
• Encouraging action across health agencies, providers, health plans, and community organizations could support more coordinated prevention and care.
• Naming cost, language, and geographic access as barriers signals that awareness alone may not be enough.

Case against#

• The resolution encourages action but does not require it, set deadlines, or provide a way to check whether agencies follow through.
• It does not provide funding or specify which activities should take priority, so the intended work may remain limited or uneven.
• The resolution does not explain how affected communities would be involved in decisions or how proposed strategies would be evaluated.